News
AEVIS VICTORIA SA – Visana Beteiligungen AG becomes a shareholder of Swiss Medical Network SA
AEVIS VICTORIA SA – Visana Beteiligungen AG becomes a shareholder of Swiss Medical Network SA
AEVIS VICTORIA SA – Fabrice Zumbrunnen joins the Board of Directors of Swiss Medical Network SA
AEVIS VICTORIA SA – Fabrice Zumbrunnen joins the Board of Directors of Swiss Medical Network SA
AEVIS VICTORIA SA – Increased revenues for the operational divisions, positive outlook for the current fiscal year. Organic growth of 9.2% in the first quarter 2023.
AEVIS VICTORIA SA – Increased revenues for the operational divisions, positive outlook for the current fiscal year. Organic growth of 9.2% in the first quarter 2023.
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders: all proposals approved
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders: all proposals approved
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders on 9 May 2023
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders on 9 May 2023
AEVIS VICTORIA SA – Publication of the Annual Report 2022
AEVIS VICTORIA SA – Publication of the Annual Report 2022
AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)
AEVIS VICTORIA SA – Consolidated EBITDA 2022 up by more than 60% to between CHF 125 and 130 million (2021: CHF 78.4m); net profit 2022 will exceed CHF 60 million (2021: CHF 4.6m)
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year.
AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million
AEVIS VICTORIA SA – AEVS.SW – Nine-month revenues up 35.5% to CHF 831.0 million
AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network
AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network
AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016
AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016
AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million
AEVIS VICTORIA SA – AEVS.SW – Half-year results 2022: Net profit jumps to CHF 47.2 million
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
AEVIS VICTORIA SA takes a stake in the Well digital health platform
AEVIS VICTORIA SA takes a stake in the Well digital health platform
AEVIS VICTORIA SA – First quarter 2022 consolidated revenue up by 61.6% to CHF 316.3 million
AEVIS VICTORIA SA – First quarter 2022 consolidated revenue up by 61.6% to CHF 316.3 million
AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA
AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved
COLTENE is optimistic for the future despite a challenging financial year 2023
COLTENE is optimistic for the future despite a challenging financial year 2023
First half results 2023/24: Substantial acceleration in sales growth expected as temporary headwinds subside
First half results 2023/24: Substantial acceleration in sales growth expected as temporary headwinds subside
Gilbert Achermann to be nominated as a new member of the Sonova Board of Directors
Gilbert Achermann to be nominated as a new member
of the Sonova Board of Directors
Dominik Arnold to become new CEO of the COLTENE Group
Dominik Arnold to become new CEO of the COLTENE Group
H1 2023 result outperforms prior year at constant exchange rates
H1 2023 result outperforms prior year at constant exchange rates
Sonova further extends offering of Sennheiser-branded hearing solutions with All-Day Clear
Sonova further extends offering of Sennheiser-branded
hearing solutions with All-Day Clear
Annual General Shareholders’ Meeting 2023: Sonova shareholders approve all motions of the Board of Directors
Annual General Shareholders’ Meeting 2023:
Sonova shareholders approve all motions of the Board of Directors